According to our findings that Prx4 promotes inflammatory tumor microenvironment, the next question we need to ask is whether myeloid cell-specific or lymphoid cell-specific knockout of Prx4 is enough to replicate results of whole-body knockout in an in vivo colon carcinogenesis model. This evidence concerns the gene PRDX4 and neoplasm.